Is India’s First Indigenous Antibiotic Effective Against Resistant Respiratory Infections and Cancer?
Click to start listening
Synopsis
India has achieved a remarkable milestone with the development of Nafithromycin, its first indigenously discovered antibiotic. This innovation not only fights resistant respiratory infections but also holds promise for cancer patients and those with diabetes. Discover how this breakthrough is set to revolutionize healthcare in India!
Key Takeaways
- Nafithromycin is India’s first indigenous antibiotic.
- Effective against resistant respiratory infections.
- Particularly beneficial for cancer patients and diabetics.
- India aims to sequence one million human genomes.
- Significant advancements in gene therapy reported.
New Delhi, Oct 18 (NationPress) Union Minister of State (Independent Charge) for Science and Technology, Dr. Jitendra Singh, announced on Saturday that India has successfully created its first indigenously developed antibiotic, Nafithromycin. This groundbreaking antibiotic is particularly effective against resistant respiratory infections and is especially beneficial for cancer patients and individuals with poorly managed diabetes.
According to Dr. Singh, this antibiotic represents the first molecule that has been entirely conceived, developed, and clinically validated within India, marking a significant advancement towards self-sufficiency in the pharmaceutical industry.
Additionally, the minister revealed that India has sequenced over 10,000 human genomes, with plans to expand this to one million.
The gene therapy trial showcased a remarkable 60–70 percent correction rate with zero incidents of bleeding, marking a pivotal moment in India's medical research.
These findings were published in the New England Journal of Medicine, highlighting India's rising status in cutting-edge biomedical innovation.
Dr. Singh elaborated on the Anusandhan National Research Foundation (ANRF), which is a crucial initiative with a total budget of Rs 50,000 crore over five years, of which Rs 36,000 crore will be sourced from private entities.
During the inauguration of a three-day Medical Workshop focused on “Harnessing Artificial Intelligence for Multi-Omics Data Integration and Analysis,” Dr. Singh emphasized the need for India to establish a self-sustaining ecosystem to foster scientific and research advancements.
He noted that countries recognized globally for their scientific achievements have typically done so through self-sufficient, innovation-driven models that include significant participation from the private sector.
Moreover, the minister announced a significant breakthrough in gene therapy, indicating the success of the first indigenous clinical trial for Hemophilia treatment. This trial was supported by the government's Department of Biotechnology and conducted at the non-governmental Christian Medical College Vellore.
Dr. Singh also remarked on the transformative impact of artificial intelligence (AI) in reshaping healthcare accessibility, governance, and decision-making.
He commended institutions like Sir Ganga Ram Hospital for leading the way in interdisciplinary approaches that merge AI, biotechnology, and genomics to enhance healthcare outcomes.
Point of View
It's crucial to highlight India's commitment to advancing its healthcare sector. The development of Nafithromycin showcases the nation’s dedication to self-reliance and innovation. The integration of AI in medical research and the progress in gene therapy further solidify India’s position as a leader in global biomedical innovation.
NationPress
18/10/2025
Frequently Asked Questions
What is Nafithromycin?
Nafithromycin is India's first indigenously developed antibiotic effective against resistant respiratory infections, particularly advantageous for cancer patients and those with diabetes.
How is Nafithromycin different from other antibiotics?
Nafithromycin is specifically designed to combat antibiotic-resistant infections, making it a vital tool in modern medicine, especially for vulnerable populations.
What are the implications of the gene therapy trial?
The gene therapy trial reported a correction rate of 60–70 percent with zero bleeding episodes, indicating significant progress in treating conditions like Hemophilia.
How is AI being utilized in India's healthcare?
AI is being integrated into healthcare systems to enhance data analysis, improve patient outcomes, and streamline governance in medical practices.
What role does the Anusandhan National Research Foundation play?
The Anusandhan National Research Foundation supports research and innovation in India, with a focus on funding initiatives that bolster the pharmaceutical and healthcare sectors.
